6 Result(s)
-
Article
Open AccessImproving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification
Population-representative estimates of SARS-CoV-2 infection prevalence and antibody levels in specific geographic areas at different time points are needed to optimise policy responses. However, even populatio...
-
Article
Open AccessRisk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population
SARS-CoV-2 reinfections increased substantially after Omicron variants emerged. Large-scale community-based comparisons across multiple Omicron waves of reinfection characteristics, risk factors, and protectio...
-
Article
Open AccessCOVID-19 vaccination, risk-compensatory behaviours, and contacts in the UK
The physiological effects of vaccination against SARS-CoV-2 (COVID-19) are well documented, yet the behavioural effects not well known. Risk compensation suggests that gains in personal safety, as a result of ...
-
Article
Open AccessProtection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK
Following primary SARS-CoV-2 vaccination, whether boosters or breakthrough infections provide greater protection against SARS-CoV-2 infection is incompletely understood. Here we investigated SARS-CoV-2 antibod...
-
Article
Open AccessSARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection
Given high SARS-CoV-2 incidence, coupled with slow and inequitable vaccine roll-out in many settings, there is a need for evidence to underpin optimum vaccine deployment, aiming to maximise global population i...
-
Article
Open AccessAnti-spike antibody response to natural SARS-CoV-2 infection in the general population
Understanding the trajectory, duration, and determinants of antibody responses after SARS-CoV-2 infection can inform subsequent protection and risk of reinfection, however large-scale representative studies ar...
